| Quarter | Score |
|---|---|
| 2022-Q3 | 41.0 |
| 2022-Q4 | 50.1 |
| 2023-Q1 | 49.0 |
| 2023-Q2 | 63.9 |
| 2023-Q3 | 48.1 |
| 2023-Q4 | 36.0 |
| 2024-Q1 | 50.1 |
| 2024-Q2 | 73.1 |
| 2024-Q3 | 78.5 |
| 2024-Q4 | 77.9 |
| 2025-Q1 | 76.7 |
| 2025-Q2 | 77.2 |
| 2025-Q3 | 76.9 |
| 2025-Q4 | 75.0 |
| 2026-Q1 | 75.2 |
| 2026-Q2 | 75.8 |
Solid consensus with smart money net adding at reasonable prices
Trading 27.2% below funds' estimated purchase price
2 of 18 tracked funds hold CZR. Avg conviction: 0.4%. Net trimming. First tracked at $40.74 (current -27.2% vs tracked).
Icahn Capital has 0.9% in this stock
Benchmark comparison unavailable
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 17 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Icahn Capital | 0.9% | Hold |
| Citadel Advisors | 0.0% | Reduce |